WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
MPEL [Melco Crown Entertainment] 6-K: (Original Filing)
[Explanatory Note i MCE Finance Limited For the Year Ended December 31, 2014 INTRODUCTION 1 3 GLOSSARY 4 EXCHANGE RATE INFORMATION 6 SELECTED CONSOLIDATED FINANCIAL INFORMATION 7 MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 8 BUSINESS 24 MANAGEMENT 36 RELATED PARTY TRANSACTIONS 38 DESCRIPTION OF OTHER MATERIAL INDEBTEDNESS 39 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1] [Explanatory Note i Studio City Finance Limited For the Year Ended December 31, 2014 INTRODUCTION 1 4 EXCHANGE RATE INFORMATION 5 SELECTED CONSOLIDATED FINANCIAL INFORMATION 6 MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 8 BUSINESS 17 MANAGEMENT 26 RELATED PARTY TRANSACTIONS 29 DESCRIPTION OF OTHER MATERIAL INDEBTEDNESS 30 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1 ii In] [Form 6K TABLE OF CONTENTS]
HSOL [Hanwha Q CELLS] CORRESP: (Original Filing)
[April 30, 2015 VIA EDGAR Division of Corporation Finance 100 F Street, N.E. Attention: Assistant Director Office 10 Re: Hanwha Q CELLS Co., Ltd. Registration Statement on Form F-3 (File No. 333-203726) Ladies and Gentlemen: Very truly yours, Dong Chul Kim Paul Hastings LLP CORRESP 1 filename1.htm]
